Company Info
Phone(844) 528-3376
Year Established
2007
Ticker
GKOS
Exchange
NYSE
Contacts
Thomas BurnsChair & CEO
Alex Thurman
CFO
Chris M. Calcaterra
VP, Global Commercial Operations
Jay L. Katz, MD, FACS
CMO
Joseph Gilliam
President & COO
Tomas Navratil, Ph.D.
CDO
Company Description
Glaukos is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.